the data also revealed 66% of trusts who replied had at least one cancer patient forced to wait over six months to start treatment, and 69% had a worse longest wait than in 2010..
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital...
money management is the professional's independent adviser, containing a wealth of in-depth features and unique fund performance statistics...
copyright © the asahi shimbun company. all rights reserved. no reproduction or republication without written permission.